- Three patients with injection of intravitreal vascular endothelial growth factor inhibitors and subsequent exacerbation of chronic proteinuria and hypertension – PubMed (nih.gov) [9]
- Worsening proteinuria and renal function after intravitreal vascular endothelial growth factor blockade for diabetic proliferative retinopathy – PubMed (nih.gov) [19]
- Development of Collapsing Focal and Segmental Glomerulosclerosis After Receiving Intravitreal Vascular Endothelial Growth Factor Blockade – PMC (nih.gov) [12]
- Nephrotoxicity induced by intravitreal vascular endothelial growth factor inhibitors: emerging evidence – PubMed (nih.gov) [8]
- Intravitreal bevacizumab-induced exacerbation of proteinuria in diabetic nephropathy, and amelioration by switching to ranibizumab – PubMed (nih.gov) [6]
- Review of intravitreal VEGF inhibitor toxicity and report of collapsing FSGS with TMA in a patient with age-related macular degeneration | Clinical Kidney Journal | Oxford Academic (oup.com) [16]
- Refractory scleroderma renal crisis precipitated after high-dose oral corticosteroids and concurrent intravitreal injection of bevacizumab – PubMed (nih.gov) [7]
- Thrombotic Microangiopathy and Acute Kidney Injury Induced After Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors VEGF Blockade-Related TMA After Intravitreal Use – PubMed (nih.gov) [5]
- Intravitreal vascular endothelial growth factors hypertension, proteinuria, and renal injury: a concise review – PubMed (nih.gov) [29]
- GNs and TMAs Induced by Anti-VEGF and TKIs – YouTube